(WASHINGTON) -- The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) -- the first and only... Read More.
(INDIANAPOLIS) -- An Indiana family is speaking out to raise awareness after their 4-year-son developed a rare infection that led to the amputation of... Read More.